Adequate Design of Pharmacokinetic-Pharmacodynamic Studies Will Help Optimize Tuberculosis Treatment for the Future

Marieke G. G. Sturkenboom; Onno W. Akkerman; Mathieu S. Bolhuis; Wiel C. M. de Lange; Tjip S. van der Werf; Jan-Willem C. Alffenaar

doi:10.1128/AAC.05173-14

Adequate Design of Pharmacokinetic-Pharmacodynamic Studies Will Help Optimize Tuberculosis Treatment for the Future

Marieke G. G. Sturkenboom, Onno W. Akkerman, Mathieu S. Bolhuis, Wiel C. M. de Lange, Tjip S. van der Werf, Jan-Willem C. Alffenaar^*

^*Bijbehorende auteur voor dit werk

Microbes in Health and Disease (MHD)

Onderzoeksoutput › Academic › peer review

7 Citaten (Scopus)

296 Downloads (Pure)

Originele taal-2	English
Pagina's (van-tot)	2474-2474
Aantal pagina's	1
Tijdschrift	Antimicrobial Agents and Chemotherapy
Volume	59
Nummer van het tijdschrift	4
DOI's	https://doi.org/10.1128/AAC.05173-14
Status	Published - apr.-2015

Toegang tot document

10.1128/AAC.05173-14

Antimicrob._Agents_Chemother._2015_Sturkenboom_2474Final publisher's version, 109 KB

Handle.net

Permanente koppeling

Citeer dit

@article{afbcf25d521743298f1285ba962e7326,

title = "Adequate Design of Pharmacokinetic-Pharmacodynamic Studies Will Help Optimize Tuberculosis Treatment for the Future",

keywords = "1ST-LINE ANTITUBERCULOSIS DRUGS, H PLASMA-CONCENTRATIONS, CLINICAL-SIGNIFICANCE, RESISTANCE",

author = "Sturkenboom, {Marieke G. G.} and Akkerman, {Onno W.} and Bolhuis, {Mathieu S.} and {de Lange}, {Wiel C. M.} and {van der Werf}, {Tjip S.} and Alffenaar, {Jan-Willem C.}",

year = "2015",

month = apr,

doi = "10.1128/AAC.05173-14",

language = "English",

volume = "59",

pages = "2474--2474",

journal = "Antimicrobial Agents and Chemotherapy",

issn = "1098-6596",

publisher = "AMER SOC MICROBIOLOGY",

number = "4",

}

TY - JOUR

T1 - Adequate Design of Pharmacokinetic-Pharmacodynamic Studies Will Help Optimize Tuberculosis Treatment for the Future

AU - Sturkenboom, Marieke G. G.

AU - Akkerman, Onno W.

AU - Bolhuis, Mathieu S.

AU - de Lange, Wiel C. M.

AU - van der Werf, Tjip S.

AU - Alffenaar, Jan-Willem C.

PY - 2015/4

Y1 - 2015/4

KW - 1ST-LINE ANTITUBERCULOSIS DRUGS

KW - H PLASMA-CONCENTRATIONS

KW - CLINICAL-SIGNIFICANCE

KW - RESISTANCE

U2 - 10.1128/AAC.05173-14

DO - 10.1128/AAC.05173-14

M3 - Letter

C2 - 25762792

VL - 59

SP - 2474

EP - 2474

JO - Antimicrobial Agents and Chemotherapy

JF - Antimicrobial Agents and Chemotherapy

SN - 1098-6596

IS - 4

ER -